UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
New investors in 2023 must understand the current market landscape. Familiarize yourself with essential tips and strategies to thrive in investing.
28,353 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Regulatory clarity is on the horizon for digital assets as the Clarity Act advances. This guide breaks down three key...
Deregulation can tilt the odds for certain industries and investment themes. This guide explains how to spot opportun...
As AI startups eye the public markets, anthropic goes public trillion could unlock a new wave of investor opportuniti...
Wall Street bets big on SpaceX, pricing in rapid expansion across launches, Starlink, and new ventures. This guide br...
Pfizer currently draws attention for its high dividend yield, but a big payout can mask risk. This guide explains how...
Hims & Hers has shown volatility, but can the stock be undervalued? This guide breaks down the business, key risks, a...
Shares of GameStop rallied as investors weighed improved profits, strategic shifts, and mounting retailer momentum. T...
As SpaceX moves deeper into the public market, investors face a volatile ride. This article lays out credible scenari...
Investors are buzzing about United States Antimony as shipments update boosts sentiment. This article breaks down the...
A strategic partnership sparked a one-day wave for ServiceNow, lifting the stock and focus on future growth. This art...
BlackRock just became first to hit a historic $15 trillion in assets under management. This milestone signals scale, ...